Cabaletta Bio, today announced that the first patient has been dosed in the DesCAARTesâ„¢ Phase 1 clinical trial of DSG3-CAART for the treatment of ... Dec 09
Orca Bio, today announced the first clinical data from its first-generation investigational therapy,... Dec 07
BriaCell Announces Collaboration with the National Cancer Institute.... Nov 10
-Advertisements-